CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,700 | -5.3% | 7,500 | 0.0% | 0.26% | -28.7% |
| Q2 2023 | $421,050 | +24.1% | 7,500 | 0.0% | 0.36% | +16.0% |
| Q1 2023 | $339,225 | +111487.2% | 7,500 | 0.0% | 0.31% | +6.1% |
| Q4 2022 | $304 | -99.9% | 7,500 | 0.0% | 0.29% | -40.2% |
| Q3 2022 | $490,000 | +7.7% | 7,500 | 0.0% | 0.49% | +18.6% |
| Q2 2022 | $455,000 | -3.2% | 7,500 | 0.0% | 0.42% | +41.2% |
| Q1 2022 | $470,000 | -17.3% | 7,500 | 0.0% | 0.29% | -0.3% |
| Q4 2021 | $568,000 | -43.6% | 7,500 | -34.8% | 0.30% | -37.9% |
| Q3 2021 | $1,007,000 | -41.1% | 11,500 | -8.0% | 0.48% | -41.9% |
| Q2 2021 | $1,709,000 | +3.7% | 12,500 | 0.0% | 0.82% | -1.8% |
| Q1 2021 | $1,648,000 | -17.2% | 12,500 | -3.8% | 0.83% | -31.7% |
| Q4 2020 | $1,990,000 | +83.1% | 13,000 | 0.0% | 1.22% | +59.1% |
| Q3 2020 | $1,087,000 | -35.0% | 13,000 | -25.9% | 0.77% | -8.5% |
| Q2 2020 | $1,673,000 | +96.6% | 17,551 | 0.0% | 0.84% | +68.8% |
| Q1 2020 | $851,000 | -18.6% | 17,551 | +0.2% | 0.50% | -1.8% |
| Q4 2019 | $1,045,000 | +45.3% | 17,516 | -0.1% | 0.50% | +31.5% |
| Q3 2019 | $719,000 | -16.9% | 17,542 | -0.2% | 0.38% | -10.5% |
| Q2 2019 | $865,000 | +36.9% | 17,572 | +0.9% | 0.43% | +41.1% |
| Q1 2019 | $632,000 | – | 17,421 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |